Oncolytic virotherapy in head and neck cancer: A hope?

Oncolytic virotherapy in head and neck cancer: A hope?

Saved in:

Bibliographic Details
Main Authors:	Vishnu Priya Veeraraghavan, Ullas Mony
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024000670
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Environmental pollution and its link to heightened oral cancer risk: A rapidly growing public health issue
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Oncolytic virotherapy and the current approaches in veterinary medicine
by: Bengu Bilgic, et al.
Published: (2022-01-01)

Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-07-01)

CDK5RAP2: A potential prognostication biomarker for oral squamous cell carcinoma?
by: Benson Paul, et al.
Published: (2024-06-01)

A bibliometric analysis of oncolytic virotherapy combined with immunotherapy
by: Ting Zhang, et al.
Published: (2024-12-01)

Revolutionizing precision medicine in oral squamous cell carcinoma: Harnessing 3D in vitro models for translation
by: Nitesh Buldak, et al.
Published: (2024-09-01)

Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-08-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)

The replicability of oncolytic virus: Defining conditions in tumor virotherapy
by: Jianjun Paul Tian
Published: (2011-05-01)

Effects of virus-induced immunogenic cues on oncolytic virotherapy
by: Darshak K. Bhatt, et al.
Published: (2024-11-01)

“Comment on the “the impact of emotional distress on suicidal ideation in head and neck cancer patients: A review”
by: Gayathri Rengasamy, et al.
Published: (2024-09-01)

Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer
by: Julia Pannhausen, et al.
Published: (2025-04-01)

Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations
by: Alaa A. Abdelmageed, et al.
Published: (2024-12-01)

Optimizing Oncolytic Virotherapy for Malignant Glioma: From Bench to Bedside
by: Jiang W, et al.
Published: (2025-08-01)

Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma
by: Jiayu Zhang, et al.
Published: (2025-04-01)

Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01)

An in silico approach uncovering the competency of oncolytic human adenovirus 52 for targeted breast cancer virotherapy
by: Muhammad Naveed, et al.
Published: (2024-11-01)

Insights from veterinary models for advancing oncolytic virotherapy through comparative oncology
by: Almohanad A. Alkayyal
Published: (2025-05-01)

ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01)

The 16th International Oncolytic Virus Conference: Advancing oncolytic virotherapy by balancing anti-tumor and anti-viral immunity
by: Eftychia Stavrakaki, et al.
Published: (2025-03-01)

Oncolytic viruses in head and neck cancers: clinical applications and therapeutic potential
by: Aditi Gupta, et al.
Published: (2025-08-01)

Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer
by: Zong Sheng Guo, et al.
Published: (2020-05-01)

Oncolytic Virotherapies and Adjuvant Gut Microbiome Therapeutics to Enhance Efficacy Against Malignant Gliomas
by: Natalie M. Meléndez-Vázquez, et al.
Published: (2024-11-01)

Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment
by: Victoria A. Jennings, et al.
Published: (2024-12-01)

The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment
by: Jahanara Rajwani, et al.
Published: (2024-03-01)

On an Impulsive Conformable M1 Oncolytic Virotherapy Neural Network Model: Stability of Sets Analysis
by: Gani Stamov, et al.
Published: (2025-01-01)

Novel Infectivity-Enhanced Oncolytic Adenovirus with a Capsid-Incorporated Dual-Imaging Moiety for Monitoring Virotherapy in Ovarian Cancer
by: Kristopher J. Kimball, et al.
Published: (2009-09-01)

β-blocker suppresses both tumoral sympathetic neurons and perivascular macrophages during oncolytic herpes virotherapy
by: Miao Yu, et al.
Published: (2025-04-01)

Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
by: Naziia Kurmasheva, et al.
Published: (2024-05-01)

Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
by: Mark S. Ferguson, et al.
Published: (2012-01-01)

The 16th international oncolytic virotherapy conference: from in vitro to clinical studies, novel approaches in cancer therapy meeting report
by: Elena Ekrami, et al.
Published: (2025-03-01)

Oncolytic Virotherapy for Relapsed, IDH-Mutant, Grade 3 Astrocytoma: A New Promising Approach – A Case Report
by: Benjamin Gesundheit, et al.
Published: (2025-03-01)

Oncolytic virus VG161 offers new hope for refractory liver cancer
by: Jinqiu Li, et al.
Published: (2025-07-01)

Author Correction: Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
by: Naziia Kurmasheva, et al.
Published: (2024-12-01)

Targeting TBK1 potentiates oncolytic virotherapy via amplifying ICAM1-mediated NK cell immunity in chemo-resistant colorectal cancer
by: Yong Li, et al.
Published: (2025-06-01)

Tumor dynamics model with treatments by oncolytic virotherapy and MEK inhibitors involving TNF-α inhibitors: Stability analysis and optimal control
by: Daengkongkho Salinthip, et al.
Published: (2025-08-01)

Natural killer T cell immunotherapy combined with IL-15-expressing oncolytic virotherapy and PD-1 blockade mediates pancreatic tumor regression
by: Simon Gebremeskel, et al.
Published: (2022-03-01)

Bispecific T-cell engagers in oral cancer immunotherapy
by: Veeraraghavan Vishnu Priya
Published: (2024-06-01)

Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context
by: Poyee Lau, et al.
Published: (2025-08-01)

Current Development of Virotherapy in Breast Cancer: A Brief Review
by: Sasmana I., et al.
Published: (2024-12-01)